Mathes Company Inc. trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,111 shares of the company’s stock after selling 129 shares during the period. Johnson & Johnson comprises approximately […]